Total Payments
$6,147
2024 Payments
$730.40
Companies
36
Transactions
382
Medicare Patients
4,990
Medicare Billing
$521,206
Payment Breakdown by Category
Food & Beverage$6,070 (98.7%)
Education$67.00 (1.1%)
Other$10.38 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,070 | 380 | 98.7% |
| Education | $67.00 | 1 | 1.1% |
| Entertainment | $10.38 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,258 | 133 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $606.45 | 46 | $0 (2023) |
| Janssen Biotech, Inc. | $471.29 | 26 | $0 (2023) |
| Allergan Inc. | $282.97 | 21 | $0 (2018) |
| PFIZER INC. | $227.41 | 15 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $217.76 | 16 | $0 (2022) |
| Boston Scientific Corporation | $213.92 | 4 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $206.42 | 14 | $0 (2023) |
| Braintree Laboratories, Inc. | $186.60 | 10 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $151.93 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $730.40 | 30 | ABBVIE INC. ($372.42) |
| 2023 | $455.62 | 19 | AbbVie Inc. ($234.77) |
| 2022 | $481.05 | 27 | ABBVIE INC. ($257.01) |
| 2021 | $904.53 | 52 | AbbVie Inc. ($332.57) |
| 2020 | $406.89 | 28 | AbbVie Inc. ($166.17) |
| 2019 | $1,110 | 80 | AbbVie, Inc. ($384.57) |
| 2018 | $1,007 | 71 | AbbVie, Inc. ($284.92) |
| 2017 | $1,052 | 75 | AbbVie, Inc. ($225.51) |
All Payment Transactions
382 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.50 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.61 | General |
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: LIVER DISEASE | ||||||
| 10/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/03/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Immunology | ||||||
| 07/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: IMMUNOLOGY | ||||||
| 07/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: VIROLOGY | ||||||
| 06/13/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: IMMUNOLOGY | ||||||
| 05/02/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $105.52 | General |
| 04/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 998 | 1,092 | $863,975 | $107,238 |
| 2022 | 16 | 1,175 | 1,282 | $899,110 | $128,077 |
| 2021 | 17 | 1,431 | 1,655 | $813,680 | $153,140 |
| 2020 | 19 | 1,386 | 1,596 | $717,250 | $132,751 |
Total Patients
4,990
Total Services
5,625
Medicare Billing
$521,206
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 105 | 106 | $180,200 | $20,251 | 11.2% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 32 | 32 | $64,000 | $14,297 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 151 | 201 | $22,110 | $12,408 | 56.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 96 | 96 | $144,000 | $11,342 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 110 | $18,150 | $9,663 | 53.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 178 | 181 | $176,475 | $9,186 | 5.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 42 | 43 | $42,140 | $7,229 | 17.2% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 51 | 51 | $49,725 | $5,139 | 10.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 40 | 40 | $40,000 | $4,677 | 11.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 25 | 25 | $24,500 | $4,088 | 16.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 28 | 30 | $27,000 | $2,951 | 10.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,320 | $1,899 | 44.0% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2023 | 21 | 21 | $42,000 | $1,777 | 4.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 28 | $2,240 | $1,103 | 49.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,340 | $855.60 | 36.6% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 81 | 81 | $24,300 | $327.98 | 1.3% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 16 | 19 | $475.00 | $44.08 | 9.3% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 54 | 54 | $108,000 | $28,845 | 26.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 115 | 115 | $195,500 | $21,802 | 11.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 193 | 248 | $27,280 | $14,662 | 53.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 119 | 162 | $26,730 | $14,121 | 52.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 107 | 107 | $160,500 | $9,983 | 6.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 44 | 44 | $43,120 | $7,133 | 16.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 144 | 147 | $143,300 | $7,030 | 4.9% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 51 | 51 | $49,725 | $5,533 | 11.1% |
About Dr. Eric Ward, M.D
Dr. Eric Ward, M.D is a Gastroenterology healthcare provider based in Valdosta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699703041.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Ward, M.D has received a total of $6,147 in payments from pharmaceutical and medical device companies, with $730.40 received in 2024. These payments were reported across 382 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,070).
As a Medicare-enrolled provider, Ward has provided services to 4,990 Medicare beneficiaries, totaling 5,625 services with total Medicare billing of $521,206. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Valdosta, GA
- Active Since 06/28/2006
- Last Updated 01/11/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1699703041
Products in Payments
- Humira (Biological) $684.58
- HUMIRA (Biological) $408.33
- LINZESS (Drug) $378.53
- STELARA (Biological) $358.54
- RINVOQ (Biological) $330.41
- SKYRIZI (Biological) $312.40
- Entyvio (Biological) $231.27
- XELJANZ (Drug) $213.97
- VIBERZI (Drug) $186.17
- XIFAXAN (Drug) $178.77
- Amitiza (Drug) $175.48
- OCALIVA (Drug) $151.93
- Cimzia (Drug) $147.57
- INJECTAFER (Drug) $126.19
- ENTYVIO (Biological) $122.64
- GIMOTI (Drug) $121.93
- Creon (Drug) $116.44
- REMICADE (Biological) $112.75
- CLENPIQ (Drug) $110.25
- ZENPEP (Drug) $103.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.